Capricorn Fund Managers Ltd

Position in PFE — Pfizer Inc

CIK 1901361 LONDON, X0

Position in PFE

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$532,890

-$4,120,808 QoQ

Shares Held

22,130

-86.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,709

of 2,821 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capricorn Fund Managers Ltd holds $34,667,354 across 6 Drug Manufacturers - General names. PFE ranks #4 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	426,416	$22,352,726
2	ABBV	AbbVie Inc.	27,397	$6,894,181
3	GILD	Gilead Sciences, Inc.	31,200	$3,941,808
4	PFE	Pfizer Inc This page	22,130	$532,890
5	MRK	Merck & Co., Inc.	4,000	$514,000
6	JNJ	Johnson & Johnson	1,700	$431,749

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$532,890	22,130	-86.6%	Shares	Sole	2026-07-24
2026-03-31	$4,653,698	165,730	+0.1%	Shares	Sole	2026-04-24
2025-12-31	$4,122,668	165,569	-12.3%	Shares	Sole	2026-01-21
2025-06-30	$4,574,063	188,699	-8.5%	Shares	Sole	2025-07-22
2025-03-31	$5,225,412	206,212	-0.2%	Shares	Sole	2025-05-08
2024-12-31	$5,481,204	206,604	-0.1%	Shares	Sole	2025-01-17
2024-09-30	$5,985,631	206,829	0.0%	Shares	Sole	2024-10-11
2024-06-30	$5,787,075	206,829	0.0%	Shares	Sole	2024-07-12
2024-03-31	$5,739,504	206,829	+47.4%	Shares	Sole	2024-04-12
2023-12-31	$4,040,618	140,348	+1427.3%	Shares	Sole	2024-01-10
2021-12-31	$542,610	9,189	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.